Navigation Links
The Galien Foundation Announces Prix Galien USA Awards Committee, Chaired by Dr. P. Roy Vagelos
Date:4/16/2012

NEW YORK, April 16, 2012 /PRNewswire/ -- The Galien Foundation announced today the membership of its Awards Committee.  The Committee is responsible for awarding the prestigious Prix Galien USA Awards, an annual recognition of innovation in biopharmaceuticals and medical technologies.

(Logo: http://photos.prnewswire.com/prnh/20120416/NY87735LOGO )

Dr. P. Roy Vagelos, Chairman of Regeneron Pharmaceuticals and retired Chairman and Chief Executive Officer at Merck, has been named Chair of the Committee. Joining him is a group of distinguished medical scientists, including several Nobel Prize and Lasker Award recipients. The committee comprises: Drs. Richard Axel (Columbia University); Michael Brown (UT Southwestern); Laurie Glimcher (Weill Cornell Medical College); Joseph Goldstein (UT Southwestern); Paul Marks (Memorial Sloan Kettering Institute); Bengt Samuelsson (Karolinska Institute), and Marc Tessier-Lavigne (Rockefeller University).

"As a past honoree and now as Chair of the Prix Galien Awards Committee, I am honored to champion this global tradition of recognizing outstanding biomedical achievement that can improve the human condition through new treatments and technologies that advance health," said Dr. Vagelos. "Scientists come to the table with a passion to improve lives and alleviate suffering. Having seen firsthand their endeavors, we recognize the importance of honoring those achievements." 

The annual Prix Galien USA Awards recognize outstanding achievement in improving the human condition through the development of innovative medical treatments and drug therapies. The 2012 Awards Ceremony will be held on October 16th in New York City. Awards will be bestowed for products in the following categories:

  1. Best Pharmaceutical Agent,
  2. Best Biotechnology Product,
  3. Best Medical Technology. 

Companies seeking consideration for a Prix Galien USA Award can submit candidates online at www.prix-galien-usa.com. The ceremony will also include special honors to select individuals who have served to better humanity -- titled the Pro Bono Humanum Award presented by Professor Elie Wiesel, Peace Nobel Laureate, Honorary member of the Committee.

Award Committee members include:

  • Prof. Richard AXEL, M.D., Nobel Laureate, Co-director, the Kavli Institute for Brain Science, Columbia University Medical Center, New York.
  • Prof. Michael S. BROWN, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine UT Southwestern Medical Center at Dallas.
  • Prof. Laurie GLIMCHER, M.D., Cornell Provost for Medical Affairs and Dean of the Medical College, New York.
  • Prof. Joseph GOLDSTEIN, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center at Dallas.
  • Prof. Paul A. MARKS, M.D., Laboratory Head  of Cell Biology, Memorial Sloan Kettering Cancer Center, New York, President, Emeritus, MSKCC.
  • Prof. Bengt SAMUELSSON, M.D., Ph.D., Nobel Laureate, Former President of Karolinska Institute and Former chairman of the Nobel Foundation.
  • Prof. Marc TESSIER-LAVIGNE, Ph.D., President, The Rockefeller University, New York, Professor Laboratory of Brain Development and Repair.
  • Prof. P. Roy VAGELOS, M.D., Chairman of Regeneron Pharmaceuticals and retired Chairman and Chief Executive Officer  at Merck.
  • Prof. Elie WIESEL, Peace Nobel Laureate, Boston University. Honorary Member

Additional information about Committee Members and the Prix Galien Awards is available on the Galien Forum website, www.galienfoundation.org.

About the Awards

The Prix Galien Awards were created to honor medical research and pharmacology for outstanding efforts to improve the human condition though approval of innovative treatments and medicines. The winners are selected by a preeminent scientific and learned committee that included several Nobel Laureates. Past product award recipients include: Prevnar 13® (Pfizer 2011), Stelara® (Janssen 2011), Prolia®/XGEVA® (Amgen 2011), Coartem® (Novartis 2010), RotaTeq® (Merck 2010), xTAG® (Luminex 2010), Gleevec® (Novartis 2009), Nplate® (Amgen 2009), Promacta® (GSK 2009), Cellsearch® (Veridex 2009), Isentress® (Merck 2009), Selzentry® (Pfizer 2008), Soliris® (Alexion 2008), Infuse® (Wyeth 2008), Revlimid® (Celgene 2008), Januvia® (Merck 2007), Chantix® (Pfizer 2007), Humira® (Abbott 2007) and Gardasil® (Merck 2007). 

The Pro Bono Humanum Award recognizes exemplary efforts by individuals and organizations in helping mankind. The award will be presented by Professor Elie Wiesel, a Nobel Prize Laureate. Previous winners of the award include: Professor Paul Farmer (2011), President Bill Clinton and Philippe Douste-Blazy (2010); Professors Barry Bloom and Jeffrey Sachs (2009), Sheldon Segal and the Population Council (2008); and Dr. P. Roy Vagelos (2007). 

For more information visit www.galienfoundation.org


'/>"/>
SOURCE Prix Galien USA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prix Galien USA Honors Innovation in Science and Biotech Industries
2. 2010 Prix Galien USA Pro Bono Humanum Award to be Presented to UNITAID for Work In Global HIV/AIDS Effort
3. Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
4. Porter Novelli Named Agency of Record for Prix Galien USA Awards
5. 2011 Prix Galien USA Final Candidates Announced: Competing for Best Biotechnology Product and Best Pharmaceutical Agent
6. Dr. Paul Farmer Selected as 2011 Pro Bono Humanum Honoree by Prix Galien USA
7. Excellence in Scientific Innovation and Humanitarian Efforts Honored at 2011 Prix Galien Award Ceremony
8. STELARA® Awarded 2011 Prix Galien USA in Best Biotechnology Product Category
9. Kevin McHale Instrumental in Forming the Help Me Hear Foundation
10. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
11. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... ,world firsts,: , TwinLink™ - the first ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):